| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 36.480 | 51.996 | 31.973 | 59.810 | 63.318 | 63.878 | 42.996 |
| Total Income - EUR | - | - | - | 36.480 | 52.003 | 31.973 | 59.868 | 63.764 | 63.879 | 42.996 |
| Total Expenses - EUR | - | - | - | 58.432 | 46.402 | 21.083 | 37.332 | 36.179 | 57.762 | 38.238 |
| Gross Profit/Loss - EUR | - | - | - | -21.951 | 5.601 | 10.890 | 22.536 | 27.586 | 6.117 | 4.758 |
| Net Profit/Loss - EUR | - | - | - | -22.317 | 5.081 | 10.255 | 22.028 | 27.044 | 5.574 | 3.533 |
| Employees | - | - | - | 4 | 3 | 1 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Medrapid Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 29.688 | 25.344 | 21.592 | 17.235 | 13.508 | 9.852 | 6.201 |
| Current Assets | - | - | - | 5.079 | 9.396 | 12.083 | 24.427 | 38.220 | 45.643 | 44.957 |
| Inventories | - | - | - | 271 | 393 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 3.090 | 8.410 | 9.040 | 9.911 | 12.676 | 34.638 | 35.474 |
| Cash | - | - | - | 1.717 | 593 | 3.044 | 14.516 | 25.544 | 11.005 | 9.483 |
| Shareholders Funds | - | - | - | -22.567 | -17.049 | -6.470 | 15.701 | 42.794 | 48.238 | 43.460 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 61.945 | 56.398 | 44.343 | 29.264 | 11.319 | 10.227 | 9.771 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medrapid Srl